Article info

Download PDFPDF
M20 Activation Of The Trkb Receptor Pathway Using A Novel Monoclonal Antibody Agonist: Implications For The Treatment Of Huntington’s Disease

Authors

Citation

Carty N, Schmidt L, Bursow G, et al
M20 Activation Of The Trkb Receptor Pathway Using A Novel Monoclonal Antibody Agonist: Implications For The Treatment Of Huntington’s Disease

Publication history

  • First published September 17, 2014.
Online issue publication 
September 17, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.